FDA NDC Directory · JSON-LD · Markdown

Olanzapine

NDC 59746-306 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerJubilant Cadista Pharmacuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA200221
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsOLANZAPINE (5 mg/1)
Marketing started20120913
Package count1

External sources

Source: openFDA. Public-domain (CC0).